This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This is an open-label, uncontrolled phase 4 study to assess the safety and immunogenicity of the Japanese encephalitis (JE) vaccine Ixiaro® (IC51) in an elderly population.
Epistemonikos ID: 346e593f6ff85bca04d2e2f49e8d8cb1294c92b1
First added on: May 05, 2024